Annual Report 2019
Corporate Governance Statement
Reporting Period Jan. 1–Dec. 31, 2019
Home   >  Corporate Governance Statement  >  The Board of Directors  >  Introduction of the Board of Directors  >  Seppo Mäkinen


Seppo Mäkinen

b. 1952, M.Sc. Physical Chemistry
Full-time occupation: Professional Board Member 

Positions of trust:

  • Bittium Corporation, Member of the Board 2015–.
  • Optomed Corporation, Member of the Board 2019–.
  • VideoVisit Oy, Member of the Board 2018–.
  • Pathena S.A., partner 2017–.
  • Neurotar Oy, Member of the Board 2015–.

Previous work history:

  • Evondos Oy, Member of the Board 2016–2019.
  • CBRA Genomics S.A., Member of the Board 2016–2019.
  • Valirx Plc, Member of the Board 2013–2017,
    Advisor 2017–.
  • MedGroup Oy, Member of the Board 2013–2018.
  • Ginolis Oy, Member of the Board 2011–2018, Chairman of the Board 2011–2018.
  • Taikon Advisor, Managing Partner 2010–2016.
  • Merieux Développement, Regional Partner, Nordics 2010–2016.
  • Ventac Partners, Partner 2012–2016.
  • Magnasense Technologies Oy, Member of the Board 2011–2015.
  • Arcdia International Oy, Member of the Board 2011–2014.
  • Balonco, Senior Advisor, owner 2012–2013.
  • Mediracer Ltd., Chairman of the Board 2010–2013.
  • RSP Systems, Member of the Board 2010–2011.
  • Bio Fund Management Oy, Founding/Managing Partner 1997–2010.
  • Sitra, Director in Life Science 1987–1997.
  • Millipore/ Waters, Sales & Marketing 1983–1987.
  • State Institute of Agricultural Chemistry, Chemist 1980–1983.
  • Served as a Chairman or Member of the Board in Egalet A/S, SpinX Inc., Chempaq, Profos AG, Ilochip A/S, Exiqon A/S, KSH-Productor Oy, Merlin Diagnostika GmbH, Primex ASA, Rumen Oy, Millimed Inc., BioPorto A/S, Wallac, Kone Instruments, Rados Technologies, MAP Medical Technologies, Pharming NV, Bio-Orbit, Labmaster Oy, Viable Bioproducts, Fluilogic Oy.

Holdings Dec. 31, 2019:
Holds 4,308 shares in Bittium Corporation.
Independent as regards to the Company and its significant shareholders.